Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI
Journal of Magnetic Resonance Imaging, 06/22/2012
Hwang J et al. – The shape of tumors, degree of rim enhancement during early dynamic phases, and target appearance on hepatobiliary phase (HBP) were valuable for differentiating between combined hepatocellular and cholangiocarcinoma (HCC–CC) and mass–forming intrahepatic cholangiocarcinoma (ICC) on gadoxetic acid–enhanced MRI.



